• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞角蛋白表型分析无助于区分食管腺癌和贲门癌。

Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia.

作者信息

van Lier M G F, Bomhof F J, Leendertse I, Flens M, Balk A T, Loffeld R J L F

机构信息

Department of Internal Medicine, De Heel Zaans Medisch Centrum, 1500 EE Zaandam, The Netherlands.

出版信息

J Clin Pathol. 2005 Jul;58(7):722-4. doi: 10.1136/jcp.2004.024265.

DOI:10.1136/jcp.2004.024265
PMID:15976339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1770716/
Abstract

BACKGROUND

It is sometimes difficult to distinguish between cardia cancer and oesophageal cancer.

AIMS

To evaluate whether cytokeratin (CK) expression of the tumour can be of value in differentiating between the two tumour types.

METHODS

Consecutive patients with a malignant tumour in the oesophagus or stomach were recruited. Biopsy specimens were taken for routine haematoxylin and eosin staining. One tissue block with representative tissue was selected for immunohistochemical staining (CK7 and CK20).

RESULTS

Endoscopically located adenocarcinoma of the oesophagus was present in 84 patients (64 men, 20 women; mean age, 68 years; range, 44-91). Cancer located primarily in the gastric cardia was present in 63 patients (42 men, 21 women; mean age, 68 years; range, 42-88). The histological diagnosis was metastasis from a primary tumour outside the oesophagus or stomach in 19 patients. The patients were divided into three groups for the immunohistochemical analysis. Patients in group A had definite oesophageal cancer, group B patients had a definite carcinoma located in the gastric cardia, and group C patients had an obstructing tumour distal in the oesophagus at the level of the diaphragm, which could not be passed with the endoscope. Paraffin wax embedded material was available from 122 patients for immunostaining and CK analysis. There was no significant difference in expression or distribution of CK7 or CK20 in the three groups of patients.

CONCLUSION

CK phenotyping cannot distinguish between cancer arising from a Barrett's oesophagus and carcinoma originating in the gastric cardia.

摘要

背景

有时很难区分贲门癌和食管癌。

目的

评估肿瘤的细胞角蛋白(CK)表达在区分这两种肿瘤类型方面是否有价值。

方法

招募连续的食管或胃恶性肿瘤患者。取活检标本进行常规苏木精和伊红染色。选择一块具有代表性组织的组织块进行免疫组织化学染色(CK7和CK20)。

结果

84例患者存在内镜下定位的食管腺癌(64例男性,20例女性;平均年龄68岁;范围44 - 91岁)。63例患者主要位于胃贲门部的癌症(42例男性,21例女性;平均年龄68岁;范围42 - 88岁)。19例患者的组织学诊断为食管或胃外原发性肿瘤的转移。将患者分为三组进行免疫组织化学分析。A组患者患有明确的食管癌,B组患者患有明确的位于胃贲门部的癌,C组患者在食管膈水平远端有阻塞性肿瘤,内镜无法通过。122例患者有石蜡包埋材料可用于免疫染色和CK分析。三组患者中CK7或CK20的表达或分布无显著差异。

结论

CK表型分析无法区分巴雷特食管起源的癌症和胃贲门部起源的癌。

相似文献

1
Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia.细胞角蛋白表型分析无助于区分食管腺癌和贲门癌。
J Clin Pathol. 2005 Jul;58(7):722-4. doi: 10.1136/jcp.2004.024265.
2
The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma.细胞角蛋白亚群在鉴别巴雷特食管相关腺癌与胃腺癌中的应用。
Histopathology. 2001 Apr;38(4):307-11. doi: 10.1046/j.1365-2559.2001.01079.x.
3
Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.细胞角蛋白(CK7、CK20)和粘蛋白肽核心抗原(MUC1、MUC2、MUC5AC)在远端食管、食管胃交界和近端胃的腺癌、正常组织及化生组织中的免疫反应性。
Histopathology. 2003 Aug;43(2):127-34. doi: 10.1046/j.1365-2559.2003.01680.x.
4
Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.使用内镜活检标本,通过细胞角蛋白亚群区分贲门部巴雷特食管与肠化生。
Am J Gastroenterol. 2001 May;96(5):1378-82. doi: 10.1111/j.1572-0241.2001.03792.x.
5
Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features.巴雷特食管与贲门肠化生:患病率、临床、内镜及组织学特征
J Gastrointestin Liver Dis. 2014 Mar;23(1):19-25.
6
Expression of p53 protein in Barrett's adenocarcinoma and adenocarcinoma of the gastric cardia and antrum.p53蛋白在巴雷特腺癌以及贲门和胃窦腺癌中的表达。
Vojnosanit Pregl. 2005 Dec;62(12):879-85. doi: 10.2298/vsp0512879j.
7
Cytokeratin and CDX-2 expression in Barrett's esophagus.巴雷特食管中的细胞角蛋白和CDX-2表达。
Scand J Gastroenterol. 2008;43(2):132-40. doi: 10.1080/00365520701676575.
8
The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?慕尼黑巴雷特食管随访研究:仅基于内镜检查或组织学检查怀疑巴雷特食管——其临床意义是什么?
Gut. 2004 Oct;53(10):1402-7. doi: 10.1136/gut.2003.036822.
9
CDX2 and villin are useful markers of intestinal metaplasia in the diagnosis of Barrett esophagus.CDX2和绒毛蛋白是诊断巴雷特食管时肠化生的有用标志物。
Am J Clin Pathol. 2008 Apr;129(4):571-7. doi: 10.1309/UWK3NAHV31GFHM3J.
10
Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.胃食管交界癌的比较基因组杂交:14q31 - 32.1区域的缺失可区分食管(巴雷特食管)腺癌和贲门腺癌。
Cancer Res. 1999 Feb 1;59(3):748-52.

引用本文的文献

1
Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping.用于鉴别食管腺癌与鳞状细胞癌的免疫组织化学组合:p63、细胞角蛋白 5/6、黏蛋白 5AC 和前梯度同源物 2 的联合使用可实现最佳亚型分类。
Hum Pathol. 2012 Nov;43(11):1799-807. doi: 10.1016/j.humpath.2012.03.019. Epub 2012 Jun 28.

本文引用的文献

1
Distinction between intestinal metaplasia in the cardia and in Barrett's esophagus: the role of histology and immunohistochemistry.贲门肠化生与巴雷特食管肠化生的鉴别:组织学和免疫组织化学的作用
Hum Pathol. 2004 Mar;35(3):371-6. doi: 10.1016/j.humpath.2003.09.011.
2
The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?细胞角蛋白7和20(CK7/20)免疫组化在区分短节段巴雷特食管与胃肠化生中的应用:是否可靠?
BMC Clin Pathol. 2003 Dec 2;3(1):5. doi: 10.1186/1472-6890-3-5.
3
Cytokeratin 7/20 and mucin expression patterns in oesophageal, cardia and distal gastric adenocarcinomas.
Histopathology. 2003 Nov;43(5):453-61. doi: 10.1046/j.1365-2559.2003.01724.x.
4
Different patterns of cytokeratin expression in Barrett's esophagus--what is beyond?巴雷特食管中细胞角蛋白表达的不同模式——还有什么其他情况?
Pathol Res Pract. 2003;199(9):581-7. doi: 10.1078/0344-0338-00465.
5
Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.细胞角蛋白(CK7、CK20)和粘蛋白肽核心抗原(MUC1、MUC2、MUC5AC)在远端食管、食管胃交界和近端胃的腺癌、正常组织及化生组织中的免疫反应性。
Histopathology. 2003 Aug;43(2):127-34. doi: 10.1046/j.1365-2559.2003.01680.x.
6
The yield of UGIE: a study of a ten-year period in the 'Zaanstreek'.
Neth J Med. 2003 Jan;61(1):14-8.
7
Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.细胞角蛋白和DAS-1免疫染色显示心脏黏膜、腐蚀性食管炎和巴雷特食管之间存在相似之处。
Am J Gastroenterol. 2002 Oct;97(10):2514-23. doi: 10.1111/j.1572-0241.2002.06033.x.
8
Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach.食管胃交界腺癌中的细胞角蛋白表达:远端食管腺癌与近端胃癌的比较研究
Am J Surg Pathol. 2002 Sep;26(9):1213-21. doi: 10.1097/00000478-200209000-00012.
9
Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.细胞角蛋白7和20的应用无法区分巴雷特食管和胃贲门肠化生。
Mod Pathol. 2002 Jun;15(6):611-6. doi: 10.1038/modpathol.3880574.
10
Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction.从正常上皮到胃黏膜及胃食管交界肠化生过程中细胞角蛋白7和20表达模式的变化
Histol Histopathol. 2002 Apr;17(2):445-54. doi: 10.14670/HH-17.445.